title: Is a dose reduction of pulsed steroids feasible for treatment of cardiac allograft rejection beyond 6 months?
authors.affiliation: Department of Cardiothoracic Surgery, Medical School, Hanover, FRG.
authors.forename: T
authors.initials: T
authors.lastname: Wahlers
authors.forename: B
authors.initials: B
authors.lastname: Heublein
authors.forename: J
authors.initials: J
authors.lastname: Cremer
authors.forename: H G
authors.initials: HG
authors.lastname: Fieguth
authors.forename: J
authors.initials: J
authors.lastname: Albes
authors.forename: J
authors.initials: J
authors.lastname: Kemnitz
authors.forename: A
authors.initials: A
authors.lastname: Haverich
authors.forename: H G
authors.initials: HG
authors.lastname: Borst
mesh_terms: D000328:Adult; D001379:Azathioprine / Q000627:therapeutic use; D003524:Cyclosporins / Q000627:therapeutic use; D004305:Dose-Response Relationship, Drug; D005260:Female; D006084:Graft Rejection; D016027:Heart Transplantation / Q000276:immunology*; D006801:Humans; D007165:Immunosuppression Therapy / Q000379:methods*; D008297:Male; D008775:Methylprednisolone / Q000627:therapeutic use*; D011239:Prednisolone / Q000627:therapeutic use; D013997:Time Factors; D014184:Transplantation, Homologous
chemical_list: D003524:Cyclosporins; D011239:Prednisolone; D001379:Azathioprine; D008775:Methylprednisolone